Parallax Health Sciences purchasing 19% stake in Global Career Networks

Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Thursday it is purchasing a 19% stake in Global Career Networks Inc, a provider of career solutions to one of the largest recruiter networks in the world with exposure to over one-half million recruiters and millions of C-level executives. 

By taking a minority stake in Global Career, the company is gaining access to a large population of professionals — namely doctors and other medical and healthcare providers — who may be interested in using Parallax’s Good Health Outcomes platform that allows users to remotely connect with their patients to monitor and respond to their conditions. 

“There are a number of synergistic value propositions that include the opportunity for us to create an ambassador program that will provide nurses with the ability to get some payment from us for introducing doctors, hospitals, etc. for use on our Good Health Outcomes platform,” said CEO Paul Arena.

READ: Parallax Health Sciences opts for third-party artificial intelligence for its remote healthcare platform

He also said Parallax intends to “license offerings into the healthcare channel for nurses (and others – for data outcomes optimization) and to migrate our ability to generate sales on a viral basis by paying a finders fee to the nurses for referrals of those signing up to be monitored on our GHO platform”. 

As part of this effort, the company plans to release soon its Parallax Communications mobile app.

“We see an opportunity to amalgamate Parallax’s platform with our subscriber base to generate significant revenues together,” said Michael Woloshin, CEO of Global Career Networks.

Arena noted that the “transaction should be very accretive to our shareholders”.

Parallax is a data-driven, Santa Monica, California-based telehealth company focused on developing technology to make remote health care a more reliable, cost-effective option for patients.

The company’s stock recently traded up 10% to $0.19 a share on the OTC Markets.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Story by ProactiveInvestors